These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30236532)

  • 1. Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens.
    Kala S; Watson B; Zhang JG; Papp E; Guzman Lenis M; Dennehy M; Cameron DW; Harrigan PR; Serghides L
    Antiviral Res; 2018 Nov; 159():45-54. PubMed ID: 30236532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model.
    Mohan H; Atkinson K; Watson B; Brumme CJ; Serghides L
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to accelerating the study of new antiretrovirals in pregnancy.
    Abrams EJ; Calmy A; Fairlie L; Mahaka IC; Chimula L; Flynn PM; Kinuthia J; Myer L; Khoo SH; Musoke P; Zwerski S; Zech JM; Lockman S; Siberry GK
    J Int AIDS Soc; 2022 Jul; 25 Suppl 2(Suppl 2):e25916. PubMed ID: 35851757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions associated with antiretroviral therapy during pregnancy.
    Santini-Oliveira M; Grinsztejn B
    Expert Opin Drug Saf; 2014 Dec; 13(12):1623-52. PubMed ID: 25390463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced and Timely Investigation of ARVs for Use in Pregnant Women.
    Abrams EJ; Mofenson LM; Pozniak A; Lockman S; Colbers A; Belew Y; Clayden P; Mirochnick M; Siberry GK; Ford N; Khoo S; Renaud F; Vitoria M; Venter WDF; Doherty M; Penazzato M;
    J Acquir Immune Defic Syndr; 2021 Apr; 86(5):607-615. PubMed ID: 33298793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Antiretroviral Agents in Pregnant Individuals Living With HIV: Current Status and Considerations for Study Design and Interpretation.
    Choi SY; Yang X; Belew Y; Struble K; Reynolds K
    J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S176-S187. PubMed ID: 37317501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV.
    Waalewijn H; Turkova A; Rakhmanina N; Cressey TR; Penazzato M; Colbers A; Burger DM;
    Ther Drug Monit; 2019 Aug; 41(4):431-443. PubMed ID: 31008997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of antiretroviral drug initiation to pregnant women of unknown HIV status during labour and delivery in Cameroon.
    Bongajum AY; Dufe DM; Tjek PTB; Goon DT; Nkenfou CN; Nwobegahay JM; Mbu R
    Afr J AIDS Res; 2018 Sep; 17(3):265-271. PubMed ID: 30319023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.
    Nirogi R; Bhyrapuneni G; Kandikere V; Muddana N; Saralaya R; Komarneni P; Mudigonda K; Mukkanti K
    Biopharm Drug Dispos; 2012 Jul; 33(5):265-77. PubMed ID: 22610784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
    Kiser JJ; Anderson PL; Gerber JG
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):61-7. PubMed ID: 16091250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using computer-based monitoring and intervention to prevent harmful combinations of antiretroviral drugs in the New York State AIDS Drug Assistance Program.
    Gonzalez CJ; Rivera CA; Martin RJ; Mergian GA; Cruz H; Agins BD
    Jt Comm J Qual Patient Saf; 2012 Jun; 38(6):269-76. PubMed ID: 22737778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in the management of HIV-infected patients.
    Ivanovic J; Nicastri E; Ascenzi P; Bellagamba R; De Marinis E; Notari S; Pucillo LP; Tozzi V; Ippolito G; Narciso P
    Curr Med Chem; 2008; 15(19):1925-39. PubMed ID: 18691049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pill burden in HIV infection: 20 years of experience.
    Krentz HB; Cosman I; Lee K; Ming JM; Gill MJ
    Antivir Ther; 2012; 17(5):833-40. PubMed ID: 22358155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.